Staff shortages in the NHS and civil service and disruption at ports will only compound difficulties of delivery
Well before scientists were sure that a vaccine would be ready for use in the UK by the end of this year, the government regulator – the Medicines and Healthcare products Regulatory Agency (MHRA) – put out an urgent call for help. Its appeal, issued in September, was evidence that even if a vaccine were to be developed and approved soon, things would be far from plain sailing.
The call to tender stated: “The MHRA urgently seeks an artificial intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine-adverse drug reactions (ADRs) and ensure that no details from the ADRs’ reaction text are missed. For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine, MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool…”
Continue reading…Staff shortages in the NHS and civil service and disruption at ports will only compound difficulties of deliveryCoronavirus – latest updatesSee all our coronavirus coverageWell before scientists were sure that a vaccine would be ready for use in the UK by the end of this year, the government regulator – the Medicines and Healthcare products Regulatory Agency (MHRA) – put out an urgent call for help. Its appeal, issued in September, was evidence that even if a vaccine were to be developed and approved soon, things would be far from plain sailing.The call to tender stated: “The MHRA urgently seeks an artificial intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine-adverse drug reactions (ADRs) and ensure that no details from the ADRs’ reaction text are missed. For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine, MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool…” Continue reading…